tetano
Editor, Senior Moderator
Front Immunol. 2015 Jun 4;6:289. doi: 10.3389/fimmu.2015.00289. eCollection 2015.
[h=1]Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy.[/h] Kay AW[SUP]1[/SUP], Blish CA[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Pregnant women are at high risk from influenza due to disproportionate morbidity, mortality, and adverse pregnancy outcomes following infection. As such, they are classified as a high-priority group for vaccination. However, changes in the maternal immune system required to accommodate the allogeneic fetus may alter the immunogenicity of influenza vaccines. A large number of studies have evaluated the safety of the influenza vaccine. Here, we will review available studies on the immunogenicity and efficacy of the influenza vaccine during pregnancy, focusing on both humoral and cellular immunity.
[h=4]KEYWORDS:[/h] antibody; immunogenicity; inactivated influenza vaccine; influenza; pregnancy
PMID: 26089824 [PubMed] PMCID: PMC4455389 Free PMC Article
[h=1]Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy.[/h] Kay AW[SUP]1[/SUP], Blish CA[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Pregnant women are at high risk from influenza due to disproportionate morbidity, mortality, and adverse pregnancy outcomes following infection. As such, they are classified as a high-priority group for vaccination. However, changes in the maternal immune system required to accommodate the allogeneic fetus may alter the immunogenicity of influenza vaccines. A large number of studies have evaluated the safety of the influenza vaccine. Here, we will review available studies on the immunogenicity and efficacy of the influenza vaccine during pregnancy, focusing on both humoral and cellular immunity.
[h=4]KEYWORDS:[/h] antibody; immunogenicity; inactivated influenza vaccine; influenza; pregnancy
PMID: 26089824 [PubMed] PMCID: PMC4455389 Free PMC Article